Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16


Sleeping sickness.

Malvy D, Chappuis F.

Clin Microbiol Infect. 2011 Jul;17(7):986-95. doi: 10.1111/j.1469-0691.2011.03536.x. Review.


Health care-seeking behaviour and diagnostic delays for Human African Trypanosomiasis in the Democratic Republic of the Congo.

Hasker E, Lumbala C, Mbo F, Mpanya A, Kande V, Lutumba P, Boelaert M.

Trop Med Int Health. 2011 Jul;16(7):869-74. doi: 10.1111/j.1365-3156.2011.02772.x. Epub 2011 Mar 29.


Fexinidazole--a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness.

Torreele E, Bourdin Trunz B, Tweats D, Kaiser M, Brun R, Mazué G, Bray MA, Pécoul B.

PLoS Negl Trop Dis. 2010 Dec 21;4(12):e923. doi: 10.1371/journal.pntd.0000923.


The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases.

Simarro PP, Cecchi G, Paone M, Franco JR, Diarra A, Ruiz JA, Fèvre EM, Courtin F, Mattioli RC, Jannin JG.

Int J Health Geogr. 2010 Nov 1;9:57. doi: 10.1186/1476-072X-9-57.


Human African trypanosomiasis in areas without surveillance.

Chappuis F, Lima MA, Flevaud L, Ritmeijer K.

Emerg Infect Dis. 2010 Feb;16(2):354-6. doi: 10.3201/eid1602.090967. No abstract available.


Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.

Priotto G, Kasparian S, Mutombo W, Ngouama D, Ghorashian S, Arnold U, Ghabri S, Baudin E, Buard V, Kazadi-Kyanza S, Ilunga M, Mutangala W, Pohlig G, Schmid C, Karunakara U, Torreele E, Kande V.

Lancet. 2009 Jul 4;374(9683):56-64. doi: 10.1016/S0140-6736(09)61117-X. Epub 2009 Jun 24.


Estimates of the duration of the early and late stage of gambiense sleeping sickness.

Checchi F, Filipe JA, Haydon DT, Chandramohan D, Chappuis F.

BMC Infect Dis. 2008 Feb 8;8:16. doi: 10.1186/1471-2334-8-16.


[Medicine and health in the Democratic Republic of Congo: from Independence to the Third Republic].

Wembonyama S, Mpaka S, Tshilolo L.

Med Trop (Mars). 2007 Oct;67(5):447-57. French.


Drug toxicity and cost as barriers to community participation in HAT control in the Democratic Republic of Congo.

Robays J, Lefèvre P, Lutumba P, Lubanza S, Kande Betu Ku Mesu V, Van der Stuyft P, Boelaert M.

Trop Med Int Health. 2007 Feb;12(2):290-8.


Trypanosomiasis control, Democratic Republic of Congo, 1993-2003.

Lutumba P, Robays J, Miaka mia Bilenge C, Mesu VK, Molisho D, Declercq J, Van der Veken W, Meheus F, Jannin J, Boelaert M.

Emerg Infect Dis. 2005 Sep;11(9):1382-8.


The effectiveness of active population screening and treatment for sleeping sickness control in the Democratic Republic of Congo.

Robays J, Bilengue MM, Van der Stuyft P, Boelaert M.

Trop Med Int Health. 2004 May;9(5):542-50.


Sleeping sickness resurgence in the DRC: the past decade.

Van Nieuwenhove S, Betu-Ku-Mesu VK, Diabakana PM, Declercq J, Bilenge CM.

Trop Med Int Health. 2001 May;6(5):335-41. Review.


The fall and rise of sleeping sickness.

Barrett MP.

Lancet. 1999 Apr 3;353(9159):1113-4. No abstract available.


[Detecting sleeping sickness: comparative efficacy of mobile teams and community health workers].

Laveissière C, Meda AH, Doua F, Sane B.

Bull World Health Organ. 1998;76(6):559-64. French.


[The flexibility of an integrated health service in the campaign against Trypanosoma brucei gambiense trypanosomiasis].

Debrouwere V, Pangu KA.

Ann Soc Belg Med Trop. 1989;69 Suppl 1:221-9. French.


A card-agglutination test with stained trypanosomes (C.A.T.T.) for the serological diagnosis of T. B. gambiense trypanosomiasis.

Magnus E, Vervoort T, Van Meirvenne N.

Ann Soc Belg Med Trop. 1978;58(3):169-76. No abstract available.


Supplemental Content

Support Center